Multiple Linear Regression Analysis of lncRNA–Disease Association Prediction Based on Clinical Prognosis Data

<div>ROC contrast curves of MlrLDAcp and Huang in predicting 5-year biochemical recurrence survival. The prediction accuracy of 5-year biochemical recurrence survival in MlrLDAcp improved by 4.2% (versus Huang).</div>

BioMed Research International

fig6

Figure 6

Figure 6: Multiple Linear Regression Analysis of lncRNA–Disease Association Prediction Based on Clinical Prognosis Data 